GRP
AUPH icon

Global Retirement Partners’s Aurinia Pharmaceuticals AUPH Stock Holding History

Global Retirement Partners’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$36.4K Hold
2,280
– – ﹤0.01% 2543
2025
Q3 		$25.2K Hold
2,280
– – ﹤0.01% 2285
2025
Q2 		$19.3K Buy
+2,280
New +$18.3K ﹤0.01% 2308
2024
Q4 		$20.5K Sell
2,280
-150
-6% -$1.22K ﹤0.01% 2072
2024
Q3 		$17.8K Hold
2,430
– – ﹤0.01% 2046
2024
Q2 		$13.9K Hold
2,430
– – ﹤0.01% 2165
2024
Q1 		$12.2K Sell
2,430
-100
-4% -$678 ﹤0.01% 2032
2023
Q4 		$19.7K Sell
2,530
-300
-11% -$2.47K ﹤0.01% 1764
2023
Q3 		$20.3K Sell
2,830
-10
-0.4% -$98 ﹤0.01% 1643
2023
Q2 		$27.5K Sell
2,840
-135
-5% -$1.4K ﹤0.01% 1532
2023
Q1 		$34.8K Sell
2,975
-250
-8% -$2.2K ﹤0.01% 1396
2022
Q4 		$13.9K Sell
3,225
-500
-13% -$2.9K ﹤0.01% 1632
2022
Q3 		$30K Hold
3,725
– – ﹤0.01% 1199
2022
Q2 		$37K Hold
3,725
– – ﹤0.01% 1107
2022
Q1 		$42K Sell
3,725
-600
-14% -$9.27K ﹤0.01% 1058
2021
Q4 		$99K Buy
+4,325
New +$102K 0.08% 75

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Global Retirement Partners's AUPH Position: Q4 2025 in Review

Global Retirement Partners held its Aurinia Pharmaceuticals (AUPH) position steady in Q4 2025 at 2,280 shares worth $36.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2543.

Global Retirement Partners first reported a position in AUPH in Q4 2021 and has held it in 16 quarters since. The position peaked at $99K in Q4 2021. 255 funds tracked by Wall St. Rank hold AUPH as of Q4 2025.

  • Global Retirement Partners held 2,280 shares of Aurinia Pharmaceuticals worth $36.4K as of Q4 2025.
  • Global Retirement Partners left its Aurinia Pharmaceuticals share count unchanged in Q4 2025.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #2543 holding.
  • Global Retirement Partners first reported a position in Aurinia Pharmaceuticals in Q4 2021 and has held it in 16 quarters since.
  • Global Retirement Partners's Aurinia Pharmaceuticals position peaked at $99K in Q4 2021.
  • 255 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.